胸部放疗中基于68镓通气-灌注正电子发射断层成像的中程自适应计划
一项前瞻性临床试验纳入25例接受常规分割放疗的非小细胞肺癌患者,在基线和第4周行68Ga-4D-V/Q PET/CT,为每例患者创建3个VMAT计划分别优化保护通气、灌注或解剖肺。功能肺体积在治疗中发生变化,功能肺保护技术可行,多数患者功能肺V20和/或功能平均肺剂量降低,其中III期患者降低最明显;作者认为部分患者可从第4周自适应计划中获益,中程适应的作用需进一步前瞻性研究。
要点
- 25例NSCLC患者基线和第4周行68Ga-4D-V/Q PET/CT,共生成75个自适应VMAT计划。
- 功能肺保护技术可行,解剖定义危及器官剂量无显著差异。
- 多数患者功能肺V20和/或功能平均肺剂量降低,III期患者降低最明显。
核心结论
- 功能肺体积在放疗过程中发生变化,部分患者可从第4周使用68Ga-4D-V/Q PET/CT自适应放疗计划中获益,中程适应的作用需进一步前瞻性研究。
研究设计与样本
- 前瞻性临床试验(U1111-1138-4421),纳入接受常规分割放疗的非小细胞肺癌患者,在基线和第4周行68Ga-4D-V/Q PET/CT,为每例患者创建并优化3个VMAT计划以分别保护通气肺、灌注肺或解剖肺。
主要发现
- 25例患者具有基线和第4周中程68Ga-4D-V/Q PET/CT影像,共产生75个自适应VMAT计划。
- 通气肺(HPLung)体积在16/25例患者中下降,体积变化均值为-28±515 cc(±SD,范围-996 cc至1496 cc)。
- 通气肺(HVLung)体积在13/25例患者中增加,体积变化均值为+112±590 cc(±SD,范围-1424 cc至950 cc)。
- 功能肺保护技术可行,解剖定义危及器官剂量无显著差异。
- 多数患者从灌注和/或通气功能体积接受20 Gy(fV20)和/或功能平均肺剂量(fMLD)降低中获益,fV20和fMLD降低最明显的患者为III期NSCLC。
局限性
- 作者指出中程适应的作用需进一步前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Four-Dimensional Gallium 68 Ventilation-Perfusion Positron Emission Tomography (68Ga-4D-V/Q PET/CT) allows for dynamic imaging of lung function. To date there has been no assessment of the feasibility of adapting radiation therapy plans to changes in lung function imaged at mid-treatment function using 68Ga-4D-V/Q PET/CT. This study assessed the potential reductions of dose to the functional lung when radiation therapy plans were adapted to avoid functional lung at the mid-treatment timepoint using volumetric arc radiotherapy (VMAT). METHODS: A prospective clinical trial (U1111-1138-4421) was performed in patients undergoing conventionally fractionated radiation therapy for non-small cell lung cancer (NSCLC). A 68Ga-4D-V/Q PET/CT was acquired at baseline and in the 4th week of treatment. Functional lung target volumes using the ventilated and perfused lung were created. Baseline functional volumes were compared to the week 4 V/Q functional volumes to describe the change in function over time. For each patient, 3 VMAT plans were created and optimised to spare ventilated, perfused or anatomical lung. All key dosimetry metrics were then compared including dose to target volumes, dose to organs at risk and dose to the anatomical and functional sub-units of lung. RESULTS: 25 patients had both baseline and 4 week mid treatment 68Ga-4D-V/Q PET/CT imaging. This resulted in a total of 75 adapted VMAT plans. The HPLung volume decreased in 16/25 patients with a mean of the change in volume (cc) -28 ± 515 cc [±SD, range -996 cc to 1496 cc]. The HVLung volume increased in 13/25 patients with mean of the change in volume (cc) + 112 ± 590 cc. [±SD, range -1424 cc to 950 cc]. The functional lung sparing technique was found to be feasible with no significant differences in dose to anatomically defined organs at risk. Most patients did derive a benefit with a reduction in functional volume receiving 20 Gy (fV20) and/or functional mean lung dose (fMLD) in either perfusion and/or ventilation. Patients with the most reduction in fV20 and fMLD were those with stage III NSCLC. CONCLUSION: Functional lung volumes change during treatment. Some patients benefit from using 68Ga-4D-V/Q PET/CT in the 4th week of radiation therapy to adapt radiation plans. In these patients, the role of mid-treatment adaptation requires further prospective investigation.
引用
- Bucknell N, Hardcastle N, Gunewardena R, et al. Mid-treatment adaptive planning during thoracic radiation using 68 Ventilation-Perfusion Positron emission tomography. Clin Transl Radiat Oncol. 2023. PMID: 36879654. doi:10.1016/j.ctro.2023.100599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。